SCHEMBL25682663

SCHEMBL25682663

Cn1c2ccccc2c2ccc3c(sc4cccc(C(C)(C)C)c43)c21

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALKBH5 Q6P6C2 1/20 0.44
▸ FTO Q9C0B1 1/20 0.44
▸ KDM4E B2RXH2 6/20 0.40
▸ MAPT P10636 4/20 0.40
▸ GPR3 P46089 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.37
▸ IDO1 P14902 1/20 0.37
▸ KIF11 P52732 1/20 0.35
▸ RXFP1 Q9HBX9 1/20 0.34
▸ ALDH1A1 P00352 4/20 0.33
▸ GABRP O00591 1/20 0.33
▸ GABRD O14764 1/20 0.33
▸ GABRA1 P14867 1/20 0.33
▸ GABRB1 P18505 1/20 0.33
▸ GABRG2 P18507 1/20 0.33
▸ GABRB3 P28472 1/20 0.33
▸ GABRA5 P31644 1/20 0.33
▸ GABRA3 P34903 1/20 0.33
▸ GABRA2 P47869 1/20 0.33
▸ GABRB2 P47870 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25682598 0.87 ALKBH5 (0.44) ALKBH5FTOKDM4EMAPTGPR3
SCHEMBL25682630 0.87 MAPT (0.37) ALKBH5FTOKDM4EMAPTGPR3
SCHEMBL25682594 0.87 ALKBH5 (0.44) ALKBH5FTOKDM4EMAPTGPR3
SCHEMBL25682667 0.85 ALKBH5 (0.47) ALKBH5FTOKDM4EMAPTGPR3
SCHEMBL25682427 0.84 GPR3 (0.39) ALKBH5FTOKDM4EMAPTGPR3
SCHEMBL13183677 0.83 ALKBH5 (0.50) ALKBH5FTOKDM4EMAPTGPR3
SCHEMBL25682662 0.83 MAPT (0.41) ALKBH5FTOKDM4EMAPTGPR3
SCHEMBL25682628 0.81 MAPT (0.39) ALKBH5FTOMAPTGPR3KIF11
SCHEMBL25682550 0.81 GPR3 (0.36) ALKBH5FTOKDM4EMAPTGPR3
SCHEMBL25684077 0.81 ALKBH5 (0.43) ALKBH5FTOKDM4EMAPTGPR3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT KYULUX, INC. (JP) 2023-08-24 — — US disclosed
EP-4190791-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT Kyulux, Inc. (JP) 2023-06-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265106-A1 COMPOUND, LIGHT-EMITTING MATERIAL, AND LIGHT-EMITTING ELEMENT CRY1, CCNE2, CRY2 ALKBH5 2658/4885FTO 1081/4885KDM4E 1997/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback